Authors: Sarah A Cassidy-Seyoum, Bipin Adhikari, Keoratha Chheng, Phal Chanpheakdey, Agnes Meershoek, Michelle S Hsiang, Lorenz von Seidlein, Rupam Tripura, Benedikt Ley, Ric N Price, Lek Dysoley, Kamala Thriemer, Nora Engel
This study evaluated stakeholders’ perception on whether it is possible and acceptable to bring point-of-care glucose-6-phosphate dehydrogenase (G6PD) testing for malaria treatment to communities in Cambodia. Most people agreed the testing is valuable, and village malaria workers could do it well with proper training and support. However, some concerns like cost, device approval, and performance in hot weather must be addressed. More trust from policymakers is also needed. Overall, testing in the community could work, but key challenges need solving first.
Download Resource
Resource Topic: CHW Role, Malaria
Resource Type: Qualitative
Year: 2025
Region: Asia
Country: Cambodia
Publisher May Restrict Access: No